UniProt ID | CPZIP_HUMAN | |
---|---|---|
UniProt AC | Q6JBY9 | |
Protein Name | CapZ-interacting protein | |
Gene Name | RCSD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 416 | |
Subcellular Localization | ||
Protein Description | Stress-induced phosphorylation of CAPZIP may regulate the ability of F-actin-capping protein to remodel actin filament assembly.. | |
Protein Sequence | MEERPAETNANVDNSASPSVAQLAGRFREQAAAAKETPASKPTRRKPPCSLPLFPPKVDLGQNGEEKSPPNASHPPKFKVKSSPLIEKLQANLTFDPAALLPGASPKSPGLKAMVSPFHSPPSTPSSPGVRSRPSEAEEVPVSFDQPPEGSHLPCYNKVRTRGSIKRRPPSRRFRRSQSDCGELGDFRAVESSQQNGAKEEDGDEVLPSKSKAPGSPLSSEGAAGEGVRTLGPAEKPPLRRSPSRTEKQEEDRATEEAKNGEKARRSSEEVDGQHPAQEEVPESPQTSGPEAENRCGSPREEKPAGEEAEMEKATEVKGERVQNEEVGPEHDSQETKKLEEGAAVKETPHSPPGGVKGGDVPKQEKGKEKQQEGAVLEPGCSPQTGPAQLETSSEVQSEPAVPKPEDDTPVQDTKM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MEERPAETNANVDNS CCCCCCCCCCCCCCC | 41.56 | 28464451 | |
15 | Phosphorylation | TNANVDNSASPSVAQ CCCCCCCCCCHHHHH | 26.17 | 28450419 | |
17 | Phosphorylation | ANVDNSASPSVAQLA CCCCCCCCHHHHHHH | 19.96 | 23401153 | |
19 | Phosphorylation | VDNSASPSVAQLAGR CCCCCCHHHHHHHHH | 27.82 | 28450419 | |
37 | Phosphorylation | QAAAAKETPASKPTR HHHHHHCCCCCCCCC | 24.37 | 28111955 | |
50 | Phosphorylation | TRRKPPCSLPLFPPK CCCCCCCCCCCCCCC | 38.50 | 28634298 | |
68 | Phosphorylation | GQNGEEKSPPNASHP CCCCCCCCCCCCCCC | 49.20 | 23401153 | |
73 | Phosphorylation | EKSPPNASHPPKFKV CCCCCCCCCCCCCCC | 43.07 | 22617229 | |
81 | Acetylation | HPPKFKVKSSPLIEK CCCCCCCCCCHHHHH | 45.89 | 19608861 | |
82 | Phosphorylation | PPKFKVKSSPLIEKL CCCCCCCCCHHHHHH | 39.93 | 23401153 | |
83 | Phosphorylation | PKFKVKSSPLIEKLQ CCCCCCCCHHHHHHH | 20.29 | 23401153 | |
94 | Phosphorylation | EKLQANLTFDPAALL HHHHHCCEECHHHHC | 26.29 | 26552605 | |
105 | Phosphorylation | AALLPGASPKSPGLK HHHCCCCCCCCCCCC | 38.48 | 28674151 | |
108 | Phosphorylation | LPGASPKSPGLKAMV CCCCCCCCCCCCCCC | 27.81 | 23401153 | |
112 | Acetylation | SPKSPGLKAMVSPFH CCCCCCCCCCCCCCC | 40.11 | 25953088 | |
116 | Phosphorylation | PGLKAMVSPFHSPPS CCCCCCCCCCCCCCC | 14.57 | 23401153 | |
120 | Phosphorylation | AMVSPFHSPPSTPSS CCCCCCCCCCCCCCC | 38.60 | 26846344 | |
123 | Phosphorylation | SPFHSPPSTPSSPGV CCCCCCCCCCCCCCC | 57.23 | 23401153 | |
124 | Phosphorylation | PFHSPPSTPSSPGVR CCCCCCCCCCCCCCC | 32.72 | 23401153 | |
126 | Phosphorylation | HSPPSTPSSPGVRSR CCCCCCCCCCCCCCC | 49.61 | 23401153 | |
127 | Phosphorylation | SPPSTPSSPGVRSRP CCCCCCCCCCCCCCC | 27.20 | 26846344 | |
132 | Phosphorylation | PSSPGVRSRPSEAEE CCCCCCCCCCCCCCC | 46.25 | 28450419 | |
135 | Phosphorylation | PGVRSRPSEAEEVPV CCCCCCCCCCCCCCC | 48.61 | 26657352 | |
143 | Phosphorylation | EAEEVPVSFDQPPEG CCCCCCCCCCCCCCC | 19.62 | 28450419 | |
151 | Phosphorylation | FDQPPEGSHLPCYNK CCCCCCCCCCCCCCC | 21.86 | 26552605 | |
156 | Phosphorylation | EGSHLPCYNKVRTRG CCCCCCCCCCCCCCC | 18.97 | 26552605 | |
161 | Phosphorylation | PCYNKVRTRGSIKRR CCCCCCCCCCCCCCC | 42.23 | 26437602 | |
164 | Phosphorylation | NKVRTRGSIKRRPPS CCCCCCCCCCCCCCC | 22.96 | 26437602 | |
171 | Phosphorylation | SIKRRPPSRRFRRSQ CCCCCCCCHHCCCCH | 38.48 | - | |
177 | Phosphorylation | PSRRFRRSQSDCGEL CCHHCCCCHHCCCCC | 29.76 | 23401153 | |
179 | Phosphorylation | RRFRRSQSDCGELGD HHCCCCHHCCCCCCC | 35.79 | 23401153 | |
192 | Phosphorylation | GDFRAVESSQQNGAK CCHHHHHHHHHCCCC | 27.18 | 26074081 | |
193 | Phosphorylation | DFRAVESSQQNGAKE CHHHHHHHHHCCCCC | 23.45 | 26074081 | |
209 | Phosphorylation | DGDEVLPSKSKAPGS CCCCCCCCCCCCCCC | 45.46 | 26074081 | |
211 | Phosphorylation | DEVLPSKSKAPGSPL CCCCCCCCCCCCCCC | 38.09 | 23898821 | |
216 | Phosphorylation | SKSKAPGSPLSSEGA CCCCCCCCCCCCCCC | 22.93 | 28674151 | |
219 | Phosphorylation | KAPGSPLSSEGAAGE CCCCCCCCCCCCCCC | 29.72 | 26329039 | |
220 | Phosphorylation | APGSPLSSEGAAGEG CCCCCCCCCCCCCCC | 47.97 | 26329039 | |
230 | Phosphorylation | AAGEGVRTLGPAEKP CCCCCCCCCCCCCCC | 33.39 | 26074081 | |
242 | Phosphorylation | EKPPLRRSPSRTEKQ CCCCCCCCCCHHHHH | 22.31 | 30576142 | |
244 | Phosphorylation | PPLRRSPSRTEKQEE CCCCCCCCHHHHHHH | 53.75 | 30108239 | |
246 | Phosphorylation | LRRSPSRTEKQEEDR CCCCCCHHHHHHHHH | 52.45 | 30108239 | |
255 | Phosphorylation | KQEEDRATEEAKNGE HHHHHHHHHHHHHHH | 34.94 | 26074081 | |
267 | Phosphorylation | NGEKARRSSEEVDGQ HHHHHHHCHHCCCCC | 36.23 | 23401153 | |
268 | Phosphorylation | GEKARRSSEEVDGQH HHHHHHCHHCCCCCC | 35.64 | 23401153 | |
284 | Phosphorylation | AQEEVPESPQTSGPE CCCCCCCCCCCCCHH | 19.08 | 23401153 | |
287 | Phosphorylation | EVPESPQTSGPEAEN CCCCCCCCCCHHHHH | 38.75 | 22115753 | |
288 | Phosphorylation | VPESPQTSGPEAENR CCCCCCCCCHHHHHC | 47.29 | 22115753 | |
298 | Phosphorylation | EAENRCGSPREEKPA HHHHCCCCCCCCCCC | 25.14 | 23401153 | |
333 | Phosphorylation | EVGPEHDSQETKKLE CCCCCCCCHHHHHHH | 31.65 | 23401153 | |
336 | Phosphorylation | PEHDSQETKKLEEGA CCCCCHHHHHHHCCC | 26.33 | 28450419 | |
348 | Phosphorylation | EGAAVKETPHSPPGG CCCCCCCCCCCCCCC | 22.15 | 26329039 | |
351 | Phosphorylation | AVKETPHSPPGGVKG CCCCCCCCCCCCCCC | 33.71 | 23401153 | |
382 | Phosphorylation | AVLEPGCSPQTGPAQ CCCCCCCCCCCCCCC | 26.42 | 26074081 | |
385 | Phosphorylation | EPGCSPQTGPAQLET CCCCCCCCCCCCCCC | 48.82 | 26074081 | |
392 | Phosphorylation | TGPAQLETSSEVQSE CCCCCCCCCCCCCCC | 46.26 | 28348404 | |
393 | Phosphorylation | GPAQLETSSEVQSEP CCCCCCCCCCCCCCC | 18.35 | 28348404 | |
394 | Phosphorylation | PAQLETSSEVQSEPA CCCCCCCCCCCCCCC | 49.56 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
68 | S | Phosphorylation | Kinase | MAPK8 | P45983 | Uniprot |
83 | S | Phosphorylation | Kinase | MAPK8 | P45983 | Uniprot |
108 | S | Phosphorylation | Kinase | MAPK12 | P53778 | Uniprot |
108 | S | Phosphorylation | Kinase | MAPK13 | O15264 | Uniprot |
179 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | Uniprot |
179 | S | Phosphorylation | Kinase | MAPKAPK3 | Q16644 | Uniprot |
216 | S | Phosphorylation | Kinase | MAPK8 | P45983 | Uniprot |
244 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | Uniprot |
244 | S | Phosphorylation | Kinase | MAPKAPK3 | Q16644 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CPZIP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CPZIP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CAZA1_HUMAN | CAPZA1 | physical | 15850461 | |
CAZA2_HUMAN | CAPZA2 | physical | 28514442 | |
CAPZB_HUMAN | CAPZB | physical | 28514442 | |
CAZA1_HUMAN | CAPZA1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-81, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105; SER-108; SER-116;SER-120; SER-123; SER-177; SER-179; SER-216; SER-267; SER-268 ANDSER-284, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-179, AND MASSSPECTROMETRY. | |
"The phosphorylation of CapZ-interacting protein (CapZIP) by stress-activated protein kinases triggers its dissociation from CapZ."; Eyers C.E., McNeill H., Knebel A., Morrice N., Arthur S.J.C.,Cuenda A., Cohen P.; Biochem. J. 389:127-135(2005). Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITHCAPZA2 AND CAPZB, TISSUE SPECIFICITY, AND PHOSPHORYLATION AT SER-68;SER-83; SER-108; SER-179; SER-216 AND SER-244. |